Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acura Pharmaceuticals, Inc.

0.0200
0.0000
Volume:- -
Turnover:- -
Market Cap:1.33M
PE:-1.00
High:0.0200
Open:0.0200
Low:0.0200
Close:0.0200
Loading ...

Company Profile

Company Name:
Acura Pharmaceuticals, Inc.
Exchange:
EXPERT
Establishment Date:
1935
Employees:
- -
Office Location:
616 N. North Court,Suite 120,Palatine,Illinois,United States
Zip Code:
60067
Fax:
847 705 5399
Introduction:
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was formerly known as Halsey Drug Co., Inc. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals, Inc. is a subsidiary of Abuse Deterrent Pharma, LLC.